Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies.

Susanne UlrichRolf HolleMargarethe WackerRenee StarkAndrea IcksBarbara ThorandAnnette PetersMichael Laxy

Published in: BMJ open (2016)

This study illustrates the substantial direct and indirect societal cost burden of type 2 diabetes in Germany. Strong effort is needed to optimise care to avoid progression of the disease and costly complications.

Keyphrases

type diabetes
risk factors
healthcare
palliative care
cardiovascular disease
glycemic control
insulin resistance
metabolic syndrome
case control
weight loss